• HOME>
  • Investor Relations
Japanese
  • IR News
  • News Releases
  • Jan. 17, 2020 (PDF/97KB)Corporate
    Sumitomo Dainippon Pharma announces Personnel Change
  • Jan. 09, 2020 (PDF/228KB)Corporate
    Altavant Sciences Acquires Onspira Therapeutics, Adding a Potentially Life‐Saving Treatment for Post‐Lung Transplant Patients to the Altavant Pipeline
  • Jan. 06, 2020 (PDF/20KB)R&D
    Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder
  • Dec. 28, 2019 (PDF/115KB)Corporate
    Sumitomo Dainippon Pharma Completes the Formation of the Strategic Alliance with Roivant Sciences
  • Dec. 23, 2019 (PDF/488KB)R&D
    Sunovion Announces FDA Filing Acceptance of Resubmitted New Drug Application for Apomorphine Sublingual Film

more

  • Jan. 17, 2020 (PDF/97KB)Corporate
    Sumitomo Dainippon Pharma announces Personnel Change
  • Jan. 09, 2020 (PDF/228KB)Corporate
    Altavant Sciences Acquires Onspira Therapeutics, Adding a Potentially Life‐Saving Treatment for Post‐Lung Transplant Patients to the Altavant Pipeline
  • Jan. 06, 2020 (PDF/20KB)R&D
    Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder
  • Dec. 28, 2019 (PDF/115KB)Corporate
    Sumitomo Dainippon Pharma Completes the Formation of the Strategic Alliance with Roivant Sciences
  • Dec. 23, 2019 (PDF/488KB)R&D
    Sunovion Announces FDA Filing Acceptance of Resubmitted New Drug Application for Apomorphine Sublingual Film

more

IR Calendar

  • Jan. 30, 2020
    3rd Quarter of FY2019 financial results announcement

more

  • WITH GRADE AAA Corporate Websites 2018 Nikko Investor Relations Co.,Ltd. Ranking in all listed companies in Japan

  • Internet IR Commendation Award2019